The FDA just approved a revolutionary gene-modification treatment

On Wednesday, Oct. 18, the US Food and Drug Administration approved a treatment for certain types of non-Hodgkin lymphoma that uses patient’s own genetically modified immune cells to attack cancer.

The treatment, called Yescarta, is made by California-based Gilead Sciences. It’s a form of personalized medicine called chimeric antigen receptor T-cell (CAR-T) therapy, in which some of a patient’s white blood cells are extracted, modified, and then injected back into the patient.

Yescarta...

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Hodgkin [+]    Yescarta [+]    California [+]    Gilead Sciences [+]   

More #news: